LHRH antagonists having improved solubility properties
US6627609B1 · kind B1 · utility
5Cited by
2References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 14, 2000 |
| Grant date | Sep 30, 2003 |
| Priority date | — |
| Expiry date | Mar 14, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K7/23
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to peptides which contain N-methylated amino acid units and have improved water solubility. Medicaments in which the peptides according to the invention are contained can be used for the treatment of hormone-dependent tumours and hormone-influenced non-malignant disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.